These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9480160)

  • 1. [Lymphocyte interactions in platelet concentrates from buffy coats. Determination of proliferating cells using Ki-67 antibodies].
    Müller-Steinhardt M; Klüter H; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1994; 32():66-8. PubMed ID: 9480160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiation of leukocytes in thrombocyte concentrates by APAAP staining].
    Müller-Steinhardt M; Klüter H; Kirchner H
    Beitr Infusionsther; 1992; 30():127-30. PubMed ID: 1284687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of leukocyte contamination on storage of platelet concentrates from buffy coats].
    Klüter H; Klinger M; Bauhaus M; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1994; 32():61-5. PubMed ID: 9480159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters.
    Meyer TP; Zehnter I; Hofmann B; Zaisserer J; Burkhart J; Rapp S; Weinauer F; Schmitz J; Illert WE
    J Immunol Methods; 2005 Dec; 307(1-2):150-66. PubMed ID: 16325197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of thrombocyte concentrates from buffy coats after 3 and 16 hours of storage].
    Häberle H; Schulzki T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():73-7. PubMed ID: 9480161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preparation of platelet concentrates by the light-spin/hard-spin technique.
    Dzik WH
    Transfus Sci; 1991; 12(3):171-81. PubMed ID: 10149546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
    Posch U; Kokelj M; Kostner GM; Lanzer G
    Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
    Mohr H; Bayer A; Gravemann U; Müller TH
    Transfusion; 2006 Jun; 46(6):949-55. PubMed ID: 16734811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of leukocyte-reduced platelet concentrates from buffy coats using a novel separation apparatus].
    Müller N; Krüssel H
    Beitr Infusionsther Transfusionsmed; 1994; 32():52-4. PubMed ID: 9480156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of antigens on leukocytes in banked platelet concentrates: decline in HLA-DR antigen expression and mixed lymphocyte culture stimulating capacity following storage.
    Sherman ME; Dzik WH
    Blood; 1988 Sep; 72(3):867-72. PubMed ID: 2970874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
    Gulliksson H; Sjödin A; Sandgren P; Vesterinen M; Larsson S; Diedrich B
    Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
    [No Abstract]   [Full Text] [Related]  

  • 12. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric determination of leukocytes and lymphocyte subsets in thrombocytapheresis products.
    Garritsen HS; Sibrowski W
    Beitr Infusionsther Transfusionsmed; 1994; 32():401-4. PubMed ID: 9422120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in platelet concentrates prepared from pooled buffy coats.
    Klüter H; Müller-Steinhardt M; Danzer S; Wilhelm D; Kirchner H
    Vox Sang; 1995; 69(1):38-43. PubMed ID: 7483490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
    Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
    Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.